Bone growth stimulators or BGSs are supplemental devices that are worn after a lumbar (low back) or cervical (neck) spine surgery. Bone growth stimulators can be used to assist spinal bone fuse after a failed fusion procedure. Bone growth stimulation for the cervical and lumbar spine has significant benefits after a fusion procedure. Various doctors recommend BGS for post-operative lumbar and cervical cases. A bone growth stimulator sends low intensity electrical signals to the site of fusion. These electrical signals trigger natural bone healing process of the body, which are sometimes impaired in surgery patients. The global demographic scenario is quite diverse. For instance, India is a country with more than half of the population in the youth bracket, whereas China and the U.S. have the maximum geriatric population. Bone growth stimulators have observed an implausible demand in the past few years. The early development of BGS began in the U.S. and the innovation in technology has made developed and sophisticated products to enter the market.
According to the International Osteoporosis Foundation, osteoporosis causes around 8.9 million fractures per year that is around one osteoporotic fracture every 3 seconds. Moreover, osteoporosis is expected to affect around 200 million women worldwide. Around 80%, 75%, 70% and 58% of forearm, humerus, hip and spine fractures, respectively, affects women. A fracture, especially in the spinal cord requires bone surgery. Out of these surgeries, a significant number of patients will need bone growth stimulators due to steady recovery. This in turn will drive the growth of the overall bone growth stimulator market during the forecast period.
Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/225
Increasing prevalence of vertebral fractures, especially in the geriatric population will drive the overall bone growth stimulator market
According to the International Osteoporosis Foundation, the number of vertebral fractures that are not recognized is as high 45% in North America, and 46% in Latin America. After a surgery for a vertebral fracture, there is a high risk of requiring hospitalization for another fracture in the following years. To decrease the morbidity rates in patients with a history of bone surgeries, bone growth stimulators are used extensively. As the number of cases is increasing at an alarming rate, so is the need for bone growth stimulators. This will encourage the growth of the global bone growth stimulator market in the forecast period.
As per the International Osteoporosis Foundation, white women aged 50 years are at 16% lifetime risk of occurrence of a vertebral fracture, whereas the percentage is 5 for white men. The staggering percentage of the population with risk of vertebral fracture above the age of 50 will be responsible for increased number of bone surgeries, thereby augmenting the growth of bone growth stimulators. By geography, North America is likely to dominate the bone growth stimulator industry owing to various factors such as consumer awareness about treatments related bone fracture and injury and high healthcare expenditure. Western Europe will follow North America in terms of market share. Availability of advanced public health systems and subsidies, along with high adoption of new technologies such bone growth stimulators in this region are some of the factors for this region’s high market share.
Some of the companies operating in the bone growth stimulator market in the current scenario are Orthofix International N.V., Aetna Inc., DJO LLC, Smith & Nephew, Zimmer Biomet Holdings Inc., Ossatec Benelux BV, Elizur, Bioventus LLC., Orchid Medical, IGEA S.p.A, and Verve Consulting Inc.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave,
Seattle, WA 98154
Email: [email protected]